Masilukast
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01740986)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cysteinyl leukotriene receptor 1INHIBITOR
CYSLTR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sa09012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01740986 | Phase 2 | Nov 1, 2012 | Catholic University of Korea, SamA Pharmaceutical Co., Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2012 |
| SamA Pharmaceutical Co., Ltd | For profit | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1